|9.44||-0.14 / -1.46%|
Data as of 4:00pm ET
|9.44||0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 5.50. The median estimate represents a +37.71% increase from the last price of 9.44.
The current consensus among 7 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.